Antimicrobial agents and chemotherapy

• 

  Año 2006, Vol. 50, Número 10

  • Resistance of Yersinia pestis to Antimicrobial Agents

    P. Courvalin, E. Carniel, M. Galimand

    págs. 3233-3236

    

  • Origins and Evolution of Methicillin-Resistant Staphylococcus aureus Clonal Lineages

    A. R. Gomes

    págs. 3237-3244

    

  • Pharmacokinetics and Tolerability of Daptomycin at Doses up to 12 Milligrams per Kilogram of Body Weight Once Daily in Healthy Volunteers

    D. P. Benziger, M. Benvenuto

    págs. 3245-3249

    

  • Engineered Vaginal Lactobacillus Strain for Mucosal Delivery of the Human Immunodeficiency Virus Inhibitor Cyanovirin-N

    L. A. Lagenaur, X. Liu

    págs. 3250-3259

    

  • Novel Robust Hepatitis C Virus Mouse Efficacy Model

    Y. Oei, Q. Zhu, P. W. Hollenbach, M. B. Patawaran, E. N. Garrett, D. B. Mendel

    págs. 3260-3268

    

  • Biofilm Formation by the Emerging Fungal Pathogen Trichosporon asahii: Development, Architecture, and Antifungal Resistance

    G. di Bonaventura

    págs. 3269-3276

    

  • Effect of PEX, a Noncatalytic Metalloproteinase Fragment with Integrin-Binding Activity, on Experimental Chlamydophila pneumoniae Infection

    D. Caronzolo

    págs. 3277-3282

    

  • Comparative In Vitro Efficacies and Antimicrobial Durabilities of Novel Antimicrobial Central Venous Catheters

    P. Bahna, R. Reitzel, H. Hanna

    págs. 3283-3288

    

  • Potent Antiviral Synergy between Monoclonal Antibody and Small-Molecule CCR5 Inhibitors of Human Immunodeficiency Virus Type 1

    J. D. Murga

    págs. 3289-3296

    

  • Mechanism of Active Renal Tubular Efflux of Tenofovir

    K. L. Robinson, T. Cihlar, A. S. Ray

    págs. 3297-3304

    

  • Enhanced Membrane Disruption and Antibiotic Action against Pathogenic Bacteria by Designed Histidine-Rich Peptides at Acidic pH

    A. J. Mason, G. Prevost, A. Kichler, C. Gasnier

    págs. 3305-3311

    

  • Inhibition of Filamentation Can Be Used To Treat Disseminated Candidiasis

    A. L. Lazzell, S. P. Saville

    págs. 3312-3316

    

  • Total Variation in the penA Gene of Neisseria meningitidis: Correlation between Susceptibility to beta-Lactam Antibiotics and penA Gene Heterogeneity

    P. Olcen, H. Fredlund, S. Thulin

    págs. 3317-3324

    

  • Ciprofloxacin-Resistant Gram-Negative Bacilli in the Fecal Microflora of Children

    Y. Razia, X. Qin, J. R. Johnson

    págs. 3325-3329

    

  • High-Throughput and Facile Assay of Antimicrobial Peptides Using pH-Controlled Fluorescence Resonance Energy Transfer

    Y. S. Kim, H. J. Cha

    págs. 3330-3335

    

  • Effect of Rifampin on Steady-State Pharmacokinetics of Atazanavir with Ritonavir in Healthy Volunteers

    S. Agarwala, D. M. Burger

    págs. 3336-3342

    

  • Assessment of the Drug Susceptibility of Plasmodium falciparum Clinical Isolates from Africa by Using a Plasmodium Lactate Dehydrogenase Immunodetection Assay and an Inhibitory Maximum Effect Model for Precise Measurement of the 50-Percent Inhibitory Concentration

    H. Kaddouri, S. Nakache

    págs. 3343-3349

    

  • Mycobacterium leprae Is Naturally Resistant to PA-824

    U. H. Manjunatha

    págs. 3350-3354

    

  • Impact of Inactive Empiric Antimicrobial Therapy on Inpatient Mortality and Length of Stay

    J. M. Feinglass, K. K. Scarsi

    págs. 3355-3360

    

  • The mef(E)-Carrying Genetic Element (mega) of Streptococcus pneumoniae: Insertion Sites and Association with Other Genetic Elements

    M. del Grosso

    págs. 3361-3366

    

  • Bile Salt-Stimulated Lipase from Human Milk Binds DC-SIGN and Inhibits Human Immunodeficiency Virus Type 1 Transfer to CD4^+ T Cells

    M. A. Naarding

    págs. 3367-3374

    

  • Effect of Tigecycline on Normal Oropharyngeal and Intestinal Microflora

    C. E. Nord, E. Sillerstrom

    págs. 3375-3380

    

  • Potent Antihematozoan Activity of Novel Bisthiazolium Drug T16: Evidence for Inhibition of Phosphatidylcholine Metabolism in Erythrocytes Infected with Babesia and Plasmodium spp

    G. A. Biagini, E. Richier

    págs. 3381-3388

    

  • System for Expression of Microsporidian Methionine Amino Peptidase Type 2 (MetAP2) in the Yeast Saccharomyces cerevisiae

    L. M. Weiss, H. S. Zhang, R. Upadhya

    págs. 3389-3395

    

  • High-Level Carbapenem Resistance in a Klebsiella pneumoniae Clinical Isolate Is Due to the Combination of bla~A~C~T~-~1 beta-Lactamase Production, Porin OmpK35/36 Insertional Inactivation, and Down-Regulation of the Phosphate Transport Porin PhoE

    F. M. Kaczmarek

    págs. 3396-3406

    

  • Development of a Human Immunodeficiency Virus Vector-Based, Single-Cycle Assay for Evaluation of Anti-Integrase Compounds

    R. Bona, M. Andreotti

    págs. 3407-3417

    

  • Compartmentalized Intrapulmonary Pharmacokinetics of Amphotericin B and Its Lipid Formulations

    Craig A. Layman, V. Petraitis, R. Petraitiene, A. H. Groll

    págs. 3418-3423

    

  • Role of VraSR in Antibiotic Resistance and Antibiotic-Induced Stress Response in Staphylococcus aureus

    S. Gardete

    págs. 3424-3434

    

  • Structure-Activity Relationships of Bacillus cereus and Bacillus anthracis Dihydrofolate Reductase: toward the Identification of New Potent Drug Leads

    T. M. Joska, A. C. Anderson

    págs. 3435-3443

    

  • Ribavirin Antagonizes the In Vitro Anti-Hepatitis C Virus Activity of 2'-C-Methylcytidine, the Active Component of Valopicitabine

    M. P. Windisch, L. Coelmont, J. Paeshuyse

    págs. 3444-3446